Log In
Print
BCIQ
Print
Print this Print this
 

Verdeso, desonide (formerly Desilux)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLow-potency topical steroid formulated with 0.05% desonide in emollient foam delivery vehicle
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis; Treat mild to moderate atopic dermatitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today